(S)-2-((tert-Butoxycarbonyl)amino)-3-(2-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 100mg

N-cyanobenzamide, 10g

(R)-4-Cbz-Piperazine-2-carboxylic acid methylester hydrochloride, 95.0%, 250mg

4-Butylcyclohexylamine (cis- and trans- mixture)>98.0%(GC)(T)5mL

N-Fmoc-tranexamic acid, 95.0%, 5g

2-Bromo-5-hexylthiophene>98.0%(GC)5g

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-phenylpropanoic acid, 95.0%, 100mg

1-Dimethylamino-2-propanol>98.0%(GC)(T)500mL

N-ethyl-2-(4-methyl-1-piperazinyl)ethanamine trihydrochloride, 95.0%, 1g

Ethyl 2-((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl)amino)acetate, 95.0%, 250mg

N-(2,4-dimethoxybenzyl)-2-oxo-N-(thiazol-2-yl)-2,3-dihydrobenzo[d]oxazole-6-sulfonamide, 95%, 100mg

Dimethylglyoxime disodium salt octahydrate, min. 98%, pa, 25 g, glass packaging

N1-(Pyridin-2-yl)ethane-1,2-diamine>95.0%(GC)(T)100mg